Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01332
|
|||||
| Drug Name |
Bromfenac
|
|||||
| Synonyms |
2-Amino-3-(4-bromobenzoyl)benzeneacetic acid; 2-[2-amino-3-(4-bromobenzoyl)phenyl]acetic acid; AHR-10282; BROMFENAC SODIUM; Bromfenac (INN); Bromfenac [INN]; Bromfenaco; Bromfenaco [Spanish]; Bromfenacum; Bromfenacum [Latin]; Duract; Duract (TN); Sodium 2-amino-3-(4-bromobenzoyl) phenylacetate sesquihydrate; Xibrom; Xibrom (TN); [2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid; [2-amino-3-(4-bromobenzoyl)phenyl]acetic acid; {2-amino-3-[(4-bromophenyl)carbonyl]phenyl}acetic acid
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Ocular pain [ICD11: MC18] | Approved | [1] | |||
| Ocular inflammation [ICD11: 9C61.24] | Approved | [1] | ||||
| Therapeutic Class |
Antiinflammatory Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C15H12BrNO3
|
|||||
| Canonical SMILES |
C1=CC(=C(C(=C1)C(=O)C2=CC=C(C=C2)Br)N)CC(=O)O
|
|||||
| InChI |
InChI=1S/C15H12BrNO3/c16-11-6-4-9(5-7-11)15(20)12-3-1-2-10(14(12)17)8-13(18)19/h1-7H,8,17H2,(H,18,19)
|
|||||
| InChIKey |
ZBPLOVFIXSTCRZ-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 91714-94-2
|
|||||
| Pharmaceutical Properties | Molecular Weight | 334.16 | Topological Polar Surface Area | 80.4 | ||
| Heavy Atom Count | 20 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
3.3
|
|||||
| PubChem CID | ||||||
| PubChem SID |
8187024
, 14802056
, 43118081
, 46508121
, 50065379
, 50714597
, 51091863
, 53786963
, 57288753
, 57314080
, 85433311
, 103293849
, 104321485
, 117562408
, 119526091
, 125536482
, 129879365
, 131330262
, 134338019
, 135065652
, 137005805
, 142970983
, 152227509
, 160814551
, 160964302
, 162197012
, 163089933
, 163373042
, 163837609
, 164117525
, 164175212
, 172092503
, 175268177
, 178103707
, 179151433
, 184545820
, 186004941
, 196396861
, 203081294
, 204420653
, 223388494
, 223435566
, 223484710
, 223551046
, 223656326
, 224730616
, 226420876
, 242065764
, 249847324
, 250181405
|
|||||
| ChEBI ID |
CHEBI:240107
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | OATP1B1 | Transporter Info | Organic anion transporting polypeptide 1B1 | Substrate | [2] | |
| References | ||||||
| 1 | Bromfenac was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Organic Anion Transporter 2-Mediated Hepatic Uptake Contributes to the Clearance of High-Permeability-Low-Molecular-Weight Acid and Zwitterion Drugs: Evaluation Using 25 Drugs. J Pharmacol Exp Ther. 2018 Nov;367(2):322-334. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.